Healthcare -
Biotechnology - NASDAQ - US
$ 40.79
0.841 %
$ 2.64 B
Market Cap
-17.43
P/E
KYMR - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities KYMR - Kymera Therapeutics, Inc.
140 M
LAST VALUE
84.42%
2 YEAR CAGR
153.73%
5 YEAR CAGR
0.00%
10 YEAR CAGR